Advanced Solutions Life Sciences is thrilled to announce the launch of BioApp Intelligence. This new software is a groundbreaking AI-driven solution designed to revolutionize laboratory automation. When paired with the powerful BioAssemblyBot® (BAB) Platform - the possibilities are endless.
Overview
BioApps Intelligence is an AI product that, coupled with the BioAssemblyBot® (BAB) Platform, empowers laboratories to automate simple and complex laboratory workflows, assays, and screens. With BioApp Intelligence, operators simply explain to BAB, through spoken or written natural language prompts, a desired experimental or assay workflow. BAB listens and autonomously responds!
BioApp Intelligence considers the modular capabilities of an individual BAB unit, building instructions sets that translate into the set of discrete actions driving the desired outcomes. As needed, operators can review, validate, and modify instruction sets and workflows. Realize true hands-free automation with the power of BioApps Intelligence.
Key Features
1. Natural Language Workflow Creation:
Generate workflows through spoken or written instructions.
Revise and iterate workflows interactively using natural language.
2. Versatile Automation Capabilities:
Automates tasks such as bioprinting, liquid handling, plate movement, and imaging.
Quickly adapt workflows with branching, loops, or additional steps.
3. Live Process Feedback:
The BioApp Player provides real-time tracking of all plates and operations, with options to pause, resume, or cancel workflows.
4. Integration with BioApp Maker:
Export workflows for advanced customization, including the ability to enable conditional logic.
Product Benefits
• Ease of Use: Simplifies automation with an intuitive natural language interface.
• Flexibility: Supports a wide range of laboratory workflows and processes.
• Efficiency: Reduces manual errors and accelerates experimental timelines.
• Scalability: Makes automation accessible to labs of all sizes without heavy upfront
investment.
Applications
• High-throughput drug screening.
• Tissue engineering and regenerative medicine.
Comments